Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06096597
PHASE2/PHASE3

Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome

Sponsor: David Sheyn

View on ClinicalTrials.gov

Summary

Interstitial cystitis/painful bladder syndrome (IC/PBS) is a clinical syndrome in which patients report symptoms of bladder and/or pelvic pain with pressure and/ or discomfort associated with urinary frequency and urgency. The primary objective of this study is to determine the efficacy of amniotic membrane therapy in patients with interstitial cystitis/painful bladder syndrome (IC/PBS) as defined by clinically-significant improvement in validated symptom questionnaires.

Official title: Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): a Prospective, Double-Blind, Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2024-07-24

Completion Date

2026-06

Last Updated

2025-08-17

Healthy Volunteers

Yes

Interventions

DRUG

Clarix Flo

100 mg of commercially available micronized amniotic membrane (Clarix Flo; BioTissue, Miami, FL) diluted in 10 mL of 0.9% preservative-free sodium chloride

DRUG

Placebo

10 mL of 0.9% preservative-free sodium chloride

Locations (1)

University Hospitals

Clevleand, Ohio, United States